Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/18598
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMcCarthy, RR-
dc.contributor.authorEverett, HE-
dc.contributor.authorGraham, SP-
dc.contributor.authorSteinbach, F-
dc.contributor.authorCrooke, HR-
dc.date.accessioned2019-07-03T13:54:58Z-
dc.date.available2019-07-03T13:54:58Z-
dc.date.issued2019-07-23-
dc.identifierORCID iD: Ronan R McCarthy https://orcid.org/0000-0002-7480-6352-
dc.identifier1584-
dc.identifier.citationMcCarthy, R.R. et al. (2019) 'Head Start Immunity: Characterizing the Early Protection of C Strain Vaccine Against Subsequent Classical Swine Fever Virus Infection', Frontiers in Immunology, 10, 1584, pp. 1 - 11. doi: 10.3389/fimmu.2019.01584.en_US
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/18598-
dc.descriptionSupplementary Material: The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2019.01584/full#supplementary-material .-
dc.description.abstractCopyright © 2019 McCarthy, Everett, Graham, Steinbach and Crooke. Classical Swine Fever Virus (CSFV) is an ongoing threat to the pig industry due to the high transmission and mortality rates associated with infection. Live attenuated vaccines such as the CSFV C strain vaccine are capable of protecting against infection within 5 days of vaccination, but the molecular mechanisms through which this early protection is mediated have yet to be established. In this study, we compared the response of pigs vaccinated with the C strain to non-vaccinated pigs both challenged with a pathogenic strain of CSFV. Analysis of transcriptomic data from the tonsils of these animals during the early stages after vaccination and challenge reveals a set of regulated genes that appear throughout the analysis. Many of these are linked to the ISG15 antiviral pathway suggesting it may play a role in the rapid and early protection conferred by C strain vaccination.en_US
dc.format.extent1 - 11-
dc.format.mediumElectronic-
dc.language.isoenen_US
dc.publisherFrontiers Mediaen_US
dc.rightsCopyright © 2019 McCarthy, Everett, Graham, Steinbach and Crooke. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectCSFV,en_US
dc.subjectC strain,en_US
dc.subjectISG15,en_US
dc.subjectantiviral,en_US
dc.subjectvaccinationen_US
dc.subjectinnate immunityen_US
dc.subjectClassical Swine Feveren_US
dc.titleHead Start Immunity: Characterising the early protection of C strain vaccine against subsequent classical swine fever virus infectionen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.3389/fimmu.2019.01584-
dc.relation.isPartOfFrontiers in Immunology-
pubs.publication-statusPublished-
pubs.volume10-
dc.identifier.eissn1664-3224-
dc.rights.holderMcCarthy, Everett, Graham, Steinbach and Crooke-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2019 McCarthy, Everett, Graham, Steinbach and Crooke. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.3.81 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons